The health care sector closed the day up 1.7%. Tibet Pharmaceuticals Inc ( TBET), Gentiva Health Services Inc ( GTIV), NovaBay Pharmaceuticals Inc ( NBY), and Echo Therapeutics Inc ( ECTE) were all winners today within the health care sector with Valeant Pharmaceuticals International Inc ( VRX) being today's featured health care winner. Valeant Pharmaceuticals International Inc rose 93 cents (2.6%) to $36.01 on light volume. Throughout the day, 1.9 million shares of Valeant Pharmaceuticals International Inc exchanged hands as compared to its average daily volume of 3.4 million shares.

Valeant Pharmaceuticals International, Inc., a specialty pharmaceutical company, develops, manufactures, and markets pharmaceutical products in the areas of neurology, dermatology, and branded generics. Its product portfolio comprises approximately 490 products. Valeant Pharmaceuticals International Inc has a market cap of $10.1 billion and is part of the drugs industry. Shares are up 23.9% year to date as of the close of trading on Wednesday.

TheStreet Ratings rates Valeant Pharmaceuticals International as a hold. The company's strengths can be seen in multiple areas, such as its robust revenue growth, solid stock price performance and increase in net income. However, as a counter to these strengths, we also find weaknesses including feeble growth in the company's earnings per share and disappointing return on equity.

On the negative front, World Heart Corporation ( WHRT), Telik Inc ( TELK), Fonar Corporation ( FONR), and Cormedix Inc ( CRMD) were all losers within the health care sector with Bovie Medical Corporation ( BVX) being today's health care sector Loser Spotlight stock.

For investors not wanting singular stock exposure, ETFs may be of interest. Investors who are bullish on the health care sector could consider Health Care Select Sector SPDR ( XLV) while those bearish on the health care sector could consider ProShares Ultra Short Health Care ( RXD).